CNP-miR146a improves outcomes in a two-hit acute- and ventilator-induced lung injury model

Acute respiratory distress syndrome (ARDS) has high mortality (similar to 40 %) and requires the lifesaving intervention of mechanical ventilation. A variety of systemic inflammatory insults can progress to ARDS, and the inflamed and injured lung is susceptible to ventilator-induced lung injury (VILI). Strategies to mitigate the inflammatory response while restoring pulmonary function are limited, thus we sought to determine if treatment with CNP-miR146a, a conjugate of novel free radical scavenging cerium oxide nanoparticles (CNP) to the anti-inflammatory microRNA (miR)-146a, would protect murine lungs from acute lung injury (ALI) induced with intratracheal endotoxin and subsequent VILI. Lung injury severity and treatment efficacy were evaluated via lung mechanical function, relative gene expression of inflammatory bio-markers, and lung morphometry (stereology). CNP-miR146a reduced the severity of ALI and slowed the progression of VILI, evidenced by improvements in inflammatory biomarkers, atelectasis, gas volumes in the parenchymal airspaces, and the stiffness of the pulmonary system. (C) 2023 Elsevier Inc. All rights reserved.y

Automated summary

Acute respiratory distress syndrome (ARDS) has a high mortality rate (around 40%) and often requires mechanical ventilation. The inflamed and injured lung is susceptible to ventilator-induced lung injury (VILI). This study investigated whether treatment with CNP-miR146a, a conjugate of novel free radical scavenging cerium oxide nanoparticles (CNP) to the anti-inflammatory microRNA (miR)-146a, could protect murine lungs from acute lung injury (ALI) induced by endotoxin and subsequent VILI. The results showed that CNP-miR146a reduced the severity of ALI and slowed down the progression of VILI, indicating its potential as a therapeutic approach.